| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −14.4× | −1.8× | |
| Price / Book | 4.1× | 2.0× | |
| Price / Sales | — | 3.9× | — |
| Price / Free cash flow | −16.8× | −1.6× | |
| EV / EBITDA | −14.2× | −1.2× | |
| Earnings yield | −7.0% | −13.7% | |
| Free cash flow yield | −5.9% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.66 | +3.49% | $1.21T | 58.6× | 77.8% | +19.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.36 | +2.19% | $625.03B | 23.3× | 32.9% | +34.2% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.08 | +2.26% | $510.84B | 120.9× | −129.2% | +25.9% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.26 | +3.04% | $376.33B | 31.2× | 12.8% | +17.6% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.30 | +3.25% | $365.88B | 20.0× | 34.7% | +74.9% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.64 | +2.29% | $274.94B | 19.6× | 30.5% | +16.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.82 | +2.97% | $261.82B | 25.5× | 21.1% | −0.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $687.37 | +1.18% | $254.15B | 37.7× | 12.6% | +27.5% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $438.94 | +3.29% | $237.31B | 30.8× | 89.1% | +46.9% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.51 | +2.25% | $194.07B | 22.8× | 37.5% | +27.4% |
